High Court Urged Not To Take Novo Foreign Liability Case

Law360, Washington (September 18, 2013, 6:33 PM EDT) -- A woman who alleges Novo Nordisk A/S’ hormone therapy drug Activella caused her breast cancer urged the U.S. Supreme Court on Monday not to review an Oregon state court’s decision to assert jurisdiction over the Danish drugmaker, saying the jurisdiction challenge was premature.

According to Suzanne Lukas-Werner, Novo had brought its bid for the high court to overturn the Circuit Court of Multnomah County’s decision that it holds jurisdiction over the company — under a “stream of commerce” theory involving Activella sold by a subsidiary —...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.